Cargando…

Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response

OBJECTIVE: Immune checkpoint inhibitors (ICIs) have become the standard of care in various cancers, although the predictive tool is still unknown. METHODS: This study aimed to develop a novel gene panel by selecting DNA damage response (DDR) genes from the Catalogue of Somatic Mutations in Cancer (C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yi‐Ru, Wu, Chiao‐En, Wang, Yu‐Chao, Yeh, Yi‐Chen, Lu, Meng‐Lun, Hung, Yi‐Ping, Chao, Yee, Yeh, Da‐Wei, Lin, Chien‐Hsing, Hsieh, Jason Chia‐Hsun, Chen, Ming‐Huang, Yeh, Chun‐Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326616/ https://www.ncbi.nlm.nih.gov/pubmed/32617161 http://dx.doi.org/10.1002/cti2.1145

Ejemplares similares

PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy
por: Tan, Kien Thiam, et al.
Publicado: (2020)

Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis
por: Wu, Chiao-En, et al.
Publicado: (2020)

Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma
por: Pan, Yi-Ru, et al.
Publicado: (2022)

Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma
por: Chang, John Wen‐Cheng, et al.
Publicado: (2023)

p53 as a biomarker and potential target in gastrointestinal stromal tumors
por: Wu, Chiao-En, et al.
Publicado: (2022)

Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model
por: Pan, Yi-Ru, et al.
Publicado: (2020)

ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner
por: Pan, Yi-Ru, et al.
Publicado: (2020)

Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy
por: Wu, Chiao-En, et al.
Publicado: (2021)

Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers
por: Wu, Chiao-En, et al.
Publicado: (2020)

Pediatric Liver Abscess: Trends in the Incidence, Etiology, and Outcomes Based on 20-Years of Experience at a Tertiary Center
por: Yeh, Pai-Jui, et al.
Publicado: (2020)

Auricular Point Acupressure for Chronic Low Back Pain: A Feasibility Study for 1-Week Treatment
por: Yeh, Chao-Hsing, et al.
Publicado: (2012)

Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
por: Wu, Chiao-En, et al.
Publicado: (2020)

Cytoreductive Surgery may be beneficial for highly selected patients with Metastatic Gastrointestinal Stromal Tumors receiving Regorafenib facing Local Progression: A Case Controlled Study
por: Yeh, Chun-Nan, et al.
Publicado: (2021)

Risk of Mortality and Readmission among Patients with Pelvic Fracture and Urinary Tract Infection: A Population-Based Cohort Study
por: Chen, Ying-Cheng, et al.
Publicado: (2021)

Purely laparoscopic feeding jejunostomy: a procedure which deserves more attention
por: Tsai, Hsin-I., et al.
Publicado: (2021)

Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial
por: Wu, Chiao-En, et al.
Publicado: (2021)

WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells
por: Wu, Chiao-En, et al.
Publicado: (2021)

Niclosamide Suppresses Migration and Invasion of Human Osteosarcoma Cells by Repressing TGFBI Expression via the ERK Signaling Pathway
por: Yeh, Liang-Tsai, et al.
Publicado: (2022)

ADAR2-Mediated Editing of miR-214 and miR-122 Precursor and Antisense RNA Transcripts in Liver Cancers
por: Liu, Wan-Hsin, et al.
Publicado: (2013)

Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report
por: Shen, Chia-I, et al.
Publicado: (2021)

Association of Glaucoma with the Risk of Peripheral Arterial Occlusive Disease: A Retrospective Population-Based Cohort Study
por: Yeh, Han-Wei, et al.
Publicado: (2023)

Mutation load estimation model as a predictor of the response to cancer immunotherapy
por: Lyu, Guan-Yi, et al.
Publicado: (2018)

Factors associated with pyloric hypertrophy severity and post-operative feeding and nutritional recovery in infantile hypertrophic pyloric stenosis
por: Chuang, Yao-Hung, et al.
Publicado: (2022)

Analysis of Radiopaque Gastrointestinal Foreign Bodies Expelled by Spontaneous Passage in Children: A 15-Year Single-Center Study
por: Yeh, Hung-Yu, et al.
Publicado: (2018)

mTOR Inhibitors in Advanced Biliary Tract Cancers
por: Wu, Chao-En, et al.
Publicado: (2019)

Vitamin B-6, Independent of Homocysteine, Is a Significant Factor in Relation to Inflammatory Responses for Chronic Kidney Disease and Hemodialysis Patients
por: Chen, Cheng-Hsu, et al.
Publicado: (2017)

Impact of Clinical Characteristics of Individual Metabolic Syndrome on the Severity of Insulin Resistance in Chinese Adults
por: Hsieh, Chang-Hsun, et al.
Publicado: (2007)

Macrophage migration inhibitory factor induces vascular leakage via autophagy
por: Chen, Hong-Ru, et al.
Publicado: (2015)

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
por: Wang, Shang-Yu, et al.
Publicado: (2019)

The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study
por: Hsu, Jason C., et al.
Publicado: (2021)

Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment
por: Li, Hsin-Pai, et al.
Publicado: (2021)

Polygenic Panels Predicting the Susceptibility of Multiple Upper Aerodigestive Tract Cancer in Oral Cancer Patients
por: Chien, Huei-Tzu, et al.
Publicado: (2021)

High Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma
por: Chuang, Chun-Yi, et al.
Publicado: (2017)

Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation
por: Chen, Hsin-Yeh, et al.
Publicado: (2020)

Enhancement of tendon–bone healing via the combination of biodegradable collagen-loaded nanofibrous membranes and a three-dimensional printed bone-anchoring bolt
por: Chou, Ying-Chao, et al.
Publicado: (2016)

Effect of the coronavirus disease 2019 pandemic on pediatric emergency department visits for acute gastroenteritis evaluated using a validated clinical severity score
por: Chang, En-Shuo, et al.
Publicado: (2022)

Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway
por: Chung, Shin-Yi, et al.
Publicado: (2021)

The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from Taiwan
por: Cheng, Wen‐Chien, et al.
Publicado: (2022)

Salvage surgery after definitive chemoradiotherapy through VATS for an initial unresectable locally advanced lung cancer: an alternative consolidative modality to radiotherapy?
por: Yu, Hsuan-Hsuan, et al.
Publicado: (2021)

Protective Effects of Costunolide against Hydrogen Peroxide-Induced Injury in PC12 Cells
por: Cheong, Chong-Un, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m83s9a7ndu85v2c9hcpln7q9cu